Canopy Growth Corporation Common Shares (CGC) is a publicly traded Healthcare sector company. As of May 21, 2026, CGC trades at $1.03 with a market cap of $415.34M and a P/E ratio of -0.55. CGC moved +4.57% today. Year to date, CGC is -13.45%; over the trailing twelve months it is -41.81%. Its 52-week range spans $0.77 to $5.80. Analyst consensus is buy with an average price target of $1.24. Rallies surfaces CGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CGC stock inside the company?
Recent CGC insider activity includes Yanofsky Theresa sold 10.37K, ATKINS M SHAN sold 2.07K, BAYERN JOSEPH sold 2.66K, Lazzarato David Angelo sold 15.62K, and Mongeau Luc sold 9.38K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CGC Key Metrics
Key financial metrics for CGC
Metric
Value
Price
$1.03
Market Cap
$415.34M
P/E Ratio
-0.55
EPS
$-1.88
Dividend Yield
0.24%
52-Week High
$5.80
52-Week Low
$0.77
Volume
6.61K
Avg Volume
0
Revenue (TTM)
$278.39M
Net Income
$-326.58M
Gross Margin
25.85%
Recent CGC Insider Trades
Yanofsky Theresa sold 10.37K (~$9.65K) on Mar 31, 2026.
ATKINS M SHAN sold 2.07K (~$1.93K) on Mar 31, 2026.
BAYERN JOSEPH sold 2.66K (~$2.47K) on Mar 31, 2026.
Lazzarato David Angelo sold 15.62K (~$14.53K) on Mar 31, 2026.
Recent CGC insider activity includes Yanofsky Theresa sold 10.37K, ATKINS M SHAN sold 2.07K, BAYERN JOSEPH sold 2.66K, Lazzarato David Angelo sold 15.62K, and Mongeau Luc sold 9.38K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CGC?
Yes. Rallies tracks CGC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CGC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CGC. It does not provide personalized investment advice.
